Chemed Corp. (CHE)

$549.27

+8.3

(+1.53%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $541.53
    $553.95
    $549.27
    downward going graph

    1.41%

    Downside

    Day's Volatility :2.24%

    Upside

    0.84%

    downward going graph
  • $491.81
    $654.14
    $549.27
    downward going graph

    10.46%

    Downside

    52 Weeks Volatility :24.82%

    Upside

    16.03%

    downward going graph

Returns

PeriodChemed Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-3.47%
6.5%
0.0%
6 Months
-8.55%
7.1%
0.0%
1 Year
-4.53%
9.8%
0.0%
3 Years
13.19%
14.2%
-20.2%

Highlights

Market Capitalization
8.3B
Book Value
$79.97
Dividend Share
0.8
Dividend Yield
0.29%
Earnings Per Share (EPS)
18.39
PE Ratio
29.42
PEG Ratio
2.63
Wall Street Target Price
685.0
Profit Margin
12.88%
Operating Margin TTM
14.79%
Return On Assets TTM
13.93%
Return On Equity TTM
27.87%
Revenue TTM
2.3B
Revenue Per Share TTM
154.69
Quarterly Revenue Growth YOY
7.6%
Gross Profit TTM
765.1M
EBITDA
418.9M
Diluted Eps TTM
18.39
Quarterly Earnings Growth YOY
0.33
EPS Estimate Current Year
23.21
EPS Estimate Next Year
25.28
EPS Estimate Current Quarter
5.48
EPS Estimate Next Quarter
5.7

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Chemed Corp.(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 24.71%

Current $549.27
Target $685.00

Company Financials

FY18Y/Y Change
Revenue
1.8B
↑ 6.96%
Net Income
205.5M
↑ 109.36%
Net Profit Margin
11.53%
↑ 5.64%
FY19Y/Y Change
Revenue
1.9B
↑ 8.75%
Net Income
219.9M
↑ 7.0%
Net Profit Margin
11.34%
↓ 0.19%
FY20Y/Y Change
Revenue
2.1B
↑ 7.27%
Net Income
319.5M
↑ 45.26%
Net Profit Margin
15.36%
↑ 4.02%
FY21Y/Y Change
Revenue
2.1B
↑ 2.87%
Net Income
268.6M
↓ 15.94%
Net Profit Margin
12.55%
↓ 2.81%
FY22Y/Y Change
Revenue
2.1B
↓ 0.2%
Net Income
249.6M
↓ 7.05%
Net Profit Margin
11.69%
↓ 0.86%
FY23Y/Y Change
Revenue
2.3B
↑ 6.06%
Net Income
272.5M
↑ 9.17%
Net Profit Margin
12.03%
↑ 0.34%
Q4 FY22Q/Q Change
Revenue
546.7M
↑ 3.83%
Net Income
62.1M
↑ 9.24%
Net Profit Margin
11.36%
↑ 0.56%
Q1 FY23Q/Q Change
Revenue
560.2M
↑ 2.47%
Net Income
54.1M
↓ 12.89%
Net Profit Margin
9.66%
↓ 1.7%
Q2 FY23Q/Q Change
Revenue
553.8M
↓ 1.13%
Net Income
53.4M
↓ 1.37%
Net Profit Margin
9.64%
↓ 0.02%
Q3 FY23Q/Q Change
Revenue
564.5M
↑ 1.93%
Net Income
75.0M
↑ 40.43%
Net Profit Margin
13.28%
↑ 3.64%
Q4 FY23Q/Q Change
Revenue
585.9M
↑ 3.79%
Net Income
90.1M
↑ 20.14%
Net Profit Margin
15.37%
↑ 2.09%
Q1 FY24Q/Q Change
Revenue
589.2M
↑ 0.57%
Net Income
65.0M
↓ 27.8%
Net Profit Margin
11.03%
↓ 4.34%
FY18Y/Y Change
Total Assets
975.5M
↑ 6.03%
Total Liabilities
384.2M
↑ 1.19%
FY19Y/Y Change
Total Assets
1.3B
↑ 30.01%
Total Liabilities
541.7M
↑ 41.0%
FY20Y/Y Change
Total Assets
1.4B
↑ 13.14%
Total Liabilities
533.7M
↓ 1.48%
FY21Y/Y Change
Total Assets
1.3B
↓ 6.42%
Total Liabilities
719.5M
↑ 34.8%
FY22Y/Y Change
Total Assets
1.4B
↑ 7.39%
Total Liabilities
643.3M
↓ 10.58%
FY23Y/Y Change
Total Assets
1.8B
↑ 22.11%
Total Liabilities
652.9M
↑ 1.49%
Q4 FY22Q/Q Change
Total Assets
1.4B
↑ 6.33%
Total Liabilities
643.3M
↑ 1.34%
Q1 FY23Q/Q Change
Total Assets
1.4B
↓ 0.75%
Total Liabilities
551.1M
↓ 14.33%
Q2 FY23Q/Q Change
Total Assets
1.5B
↑ 5.17%
Total Liabilities
553.1M
↑ 0.36%
Q3 FY23Q/Q Change
Total Assets
1.6B
↑ 3.78%
Total Liabilities
542.8M
↓ 1.86%
Q4 FY23Q/Q Change
Total Assets
1.8B
↑ 12.72%
Total Liabilities
652.9M
↑ 20.28%
Q1 FY24Q/Q Change
Total Assets
1.7B
↓ 1.88%
Total Liabilities
544.1M
↓ 16.66%
FY18Y/Y Change
Operating Cash Flow
287.1M
↑ 76.71%
Investing Cash Flow
-105.2M
↑ 55.64%
Financing Cash Flow
-188.2M
↑ 89.96%
FY19Y/Y Change
Operating Cash Flow
301.2M
↑ 4.91%
Investing Cash Flow
-190.8M
↑ 81.29%
Financing Cash Flow
-109.2M
↓ 42.0%
FY20Y/Y Change
Operating Cash Flow
489.3M
↑ 62.42%
Investing Cash Flow
-61.6M
↓ 67.73%
Financing Cash Flow
-271.2M
↑ 148.45%
FY21Y/Y Change
Operating Cash Flow
308.6M
↓ 36.93%
Investing Cash Flow
-57.8M
↓ 6.18%
Financing Cash Flow
-380.6M
↑ 40.34%
FY22Y/Y Change
Operating Cash Flow
309.9M
↑ 0.42%
Investing Cash Flow
-59.4M
↑ 2.85%
Financing Cash Flow
-209.3M
↓ 45.02%
Q4 FY22Q/Q Change
Operating Cash Flow
100.2M
↑ 92.63%
Investing Cash Flow
-59.4M
↑ 316.01%
Financing Cash Flow
-14.4M
↓ 63.72%
Q1 FY23Q/Q Change
Operating Cash Flow
60.5M
↓ 39.63%
Investing Cash Flow
-17.0M
↓ 71.36%
Financing Cash Flow
-59.6M
↑ 314.53%
Q2 FY23Q/Q Change
Operating Cash Flow
132.3M
↑ 118.73%
Investing Cash Flow
-16.5M
↓ 2.89%
Financing Cash Flow
-13.9M
↓ 76.62%
Q3 FY23Q/Q Change
Operating Cash Flow
28.9M
↓ 78.14%
Investing Cash Flow
-49.0M
↑ 196.42%
Financing Cash Flow
-263.0K
↓ 98.11%

Technicals Summary

Sell

Neutral

Buy

Chemed Corp. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Chemed Corp.
Chemed Corp.
-0.05%
-8.55%
-4.53%
13.19%
40.14%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
6.75%
1.59%
-22.77%
-49.63%
-45.76%
Hca Holdings, Inc.
Hca Holdings, Inc.
3.62%
24.47%
25.02%
43.55%
143.2%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
10.35%
80.65%
95.1%
108.93%
580.33%
Universal Health Services Inc.
Universal Health Services Inc.
8.08%
30.09%
44.94%
32.59%
34.96%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
0.24%
32.97%
40.81%
19.01%
139.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Chemed Corp.
Chemed Corp.
29.42
29.42
2.63
23.21
0.28
0.14
0.0
79.97
Fresenius Medical Care Ag
Fresenius Medical Care Ag
22.58
22.58
0.39
1.5
0.05
0.03
0.03
47.4
Hca Holdings, Inc.
Hca Holdings, Inc.
16.16
16.16
1.44
21.86
0.74
0.11
0.01
-6.06
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
5.46
5.46
1.74
8.98
0.54
0.07
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
15.8
15.8
1.87
13.79
0.13
0.06
0.0
93.48
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.31
16.31
1.16
9.32
0.43
0.06
NA
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Chemed Corp.
Chemed Corp.
Buy
$8.3B
40.14%
29.42
12.88%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.9B
-45.76%
22.58
2.48%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$90.1B
143.2%
16.16
8.4%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$14.6B
580.33%
5.46
12.54%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$12.4B
34.96%
15.8
5.57%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$12.6B
139.9%
16.31
6.61%

Insights on Chemed Corp.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 553.81M → 589.23M (in $), with an average increase of 2.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 90.05M → 65.01M (in $), with an average decrease of 27.8% per quarter

  • Vs THC

    In the last 1 year, Tenet Healthcare Corp.  has given 95.1% return, outperforming this stock by 99.6%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 108.9% return, outperforming this stock by 95.7%

Institutional Holdings

  • Vanguard Group Inc

    11.28%

  • BlackRock Inc

    9.69%

  • Durable Capital Partners LP

    3.78%

  • Kayne Anderson Rudnick Investment Management LLC

    3.75%

  • Neuberger Berman Group LLC

    3.39%

  • State Street Corporation

    3.10%

Corporate Announcements

  • Chemed Corp. Dividends March,2024

    In the quarter ending March,2024. Chemed Corp. has declared dividend of $0.4

    Read More

Company Information

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.

Organization
Chemed Corp.
Employees
15087
CEO
Mr. Kevin J. McNamara
Industry
Health Services

Discover More

FAQs